初級保健 POC 診斷市場 - 副產品（血糖監測、心臟代謝、尿液分析、膽固醇、傳染病、癌症標記、凝血、血液學、妊娠和生育檢測產品）、最終用途 - 全球預測，2024-2032 年

Primary Care POC Diagnostics Market - By Product (Glucose Monitoring, Cardiometabolic, Urinalysis, Cholesterol, Infectious Disease, Cancer Marker, Coagulation, Hematology, Pregnancy & Fertility Testing Products), End-use - Global Forecast, 2024-2032

出版日期: 2024年01月16日 | 出版商:

Global Market Insights Inc. | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

在技術進步以及對快速準確診斷解決方案不斷成長的需求的推動下，全球初級保健即時診斷 (POC) 市場預計在 2024 年至 2032 年將以 7% 的速度成長。

據世界衛生組織稱，非傳染性疾病每年奪走 4,100 萬人的生命，佔全球死亡人數的 74%。老年人口的不斷增加，加上糖尿病、心血管疾病和傳染病等慢性病的盛行率不斷上升，推動了對 POC 診斷工具的需求。此外，隨著技術的進步（例如攜帶式診斷設備的開發），對分散診斷測試的需求不斷成長，提高了患者的便利性並推動了採用率。

人們對疾病早期診斷的認知有所提升。這一因素加上有利的政府舉措和報銷政策，正在鼓勵醫療保健提供者將 POC 診斷融入其實踐中，從而促進市場擴張。

整個初級保健 POC 診斷行業根據產品、最終用途和地區進行分類。

預計到 2032 年，心臟代謝領域將以相當快的速度擴張。隨著全球心血管疾病和糖尿病盛行率的不斷上升，初級保健機構對快速、可靠的診斷解決方案的需求日益成長。該公司正在大力投資開發針對心臟標記、血脂檢測和 HbA1c 等疾病的 POC 診斷測試，使醫療保健提供者能夠及時採取干涉措施並改善患者的治療結果。

診斷中心部門預計到 2032 年將強勁成長，因為它們為當地社區的患者提供廣泛的測試和服務。隨著技術的進步和攜帶式診斷設備的日益普及，診斷中心現在能夠提供擴展的 POC 測試菜單，滿足患者和醫療保健提供者的不同需求。因此，診斷中心預計將在未來幾年實現顯著成長。

在龐大的人口基數、不斷成長的醫療保健支出以及人們對預防性醫療保健意識不斷提高的推動下，亞太地區初級保健定點醫療 (POC) 診斷市場將在研究期間獲得顯著地位。中國、印度和日本等國家的醫療基礎設施正在快速擴張，越來越多的初級保健診所和診斷中心採用 POC 檢測技術，推動了產業成長。

產業生態系統分析
技術景觀
監管環境
產業影響力
- 成長動力
  - 疾病盛行率呈上升趨勢和對快速診斷的需求
  - POCT設備的技術進步
  - 加大研發投入
- 產業陷阱與挑戰
  - 嚴格的監管框架
  - 產品開發成本高
成長潛力分析
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
主要市場參與者的競爭分析
競爭定位矩陣
戰略展望矩陣

第 5 章：初級保健 POC 診斷市場規模和預測：按產品分類，2018-2032 年

主要動向：按產品
血糖監測
心臟代謝檢測產品
- 心臟標記檢測產品
  - 超敏肌鈣蛋白
  - 法國巴黎銀行
  - D-二聚體
  - CK-MB
  - 肌紅蛋白
  - 其他心臟市場測試產品
- 血氣/電解質檢測產品
- HBA1C檢測產品
傳染病檢測產品
- 流感檢測產品
- HIV檢測產品
- 丙型肝炎檢測產品
- 性傳染病 (STD) 檢測產品
- 醫療保健相關感染 (HAI) 檢測產品
- 呼吸道感染檢測產品
- 熱帶疾病檢測產品
- 其他傳染病檢測產品
凝血檢測產品
- PT/INR檢測產品
- 活化凝血時間（ACT/APTT）檢測產品
懷孕和生育測試產品
- 驗孕產品
- 生育力檢測產品
腫瘤/癌症標記檢測產品
膽固醇檢測產品
血液學檢測產品
濫用藥物 (DoA) 檢測產品
糞便隱匿性檢測產品
尿液分析檢測產品
其他產品

第 6 章：初級保健 POC 診斷市場規模和預測：按最終用途分類，2018-2032 年

主要動向：依最終用途
醫院
診斷中心
研究實驗室
居家照護環境
其他最終用戶

第 7 章：初級保健 POC 診斷市場規模和預測：按地區分類，2018-2032 年

主要動向：按地區
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 沙烏地阿拉伯
- 南非
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 8 章：公司簡介

Abbott Laboratories
ACON Laboratories, Inc.
Becton, Dickinson, and Company
BioMerieux SA
Bio-Rad Laboratories, Inc.
Dexcom, Inc.
Dragerwerk Ag & Co.
F. Hoffmann-La Roche
HemoCue AB (Danaher Corporation)
Nova Biomedical
Siemens Healthineers AG
Sysmex Corporation

簡介目錄

Product Code: 7895

The global primary care point-of-care (POC) diagnostics market is expected to grow at a rate of 7% during 2024 and 2032, driven by technological advancements, and the growing demand for rapid & accurate diagnostic solutions.

According to WHO, NCDs claim 41 million lives annually, comprising 74% of global fatalities. The rising geriatric population, coupled with the increasing prevalence of chronic diseases such as diabetes, cardiovascular diseases, and infectious diseases is pushing the demand for POC diagnostic tools. Additionally, the growing demand for decentralized diagnostic testing, in consort with the advancements in technology, such as the development of portable diagnostic devices, are enhancing patient convenience and driving adoption rates.

There is improved awareness about the early diagnosis of ailments. This factor, alongside favorable government initiatives and reimbursement policies are encouraging healthcare providers to integrate POC diagnostics into their practices, fostering market expansion.

The overall primary care POC diagnostics industry is classified based on product, end-use, and region.

The cardiometabolic segment is anticipated to expand at a decent pace till 2032. With the rising prevalence of cardiovascular diseases and diabetes worldwide, there is a growing need for rapid and reliable diagnostic solutions in primary care settings. Companies are investing heavily in the development of POC diagnostic tests for conditions such as cardiac markers, lipid panels, and HbA1c, empowering healthcare providers to make timely interventions and improve patient outcomes.

The diagnostic centers segment is poised to grow robustly through 2032, as they offer a wide range of tests and services to patients in their local communities. With advancements in technology and the increasing availability of portable diagnostic devices, diagnostic centers are now able to offer an expanded menu of POC tests, catering to the diverse needs of patients and healthcare providers alike. As a result, diagnostic centers are poised to experience significant growth in the coming years.

Asia Pacific primary care point-of-care (POC) diagnostics market is set to gain prominence during the study period, propelled by the large population base, coupled with rising healthcare expenditures, and increasing awareness about preventive healthcare. Countries such as China, India, and Japan are witnessing a rapid expansion of their healthcare infrastructure, with a growing number of primary care clinics and diagnostic centers adopting POC testing technologies, thereby fueling industry growth.

Chapter 1 Methodology and Scope

1.1 Market scope and definition
1.2 Base estimates and working
1.3 Forecast calculations
1.4 Data sources
- 1.4.1 Primary
- 1.4.2 Secondary
  - 1.4.2.1 Paid sources
  - 1.4.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Global primary care POC diagnostics market 360 degree synopsis, 2018 - 2032
- 2.1.1 Regional trends
- 2.1.2 Product trends
- 2.1.3 End-use trends

Chapter 3 Primary Care POC Diagnostics Industry Insights

3.1 Industry ecosystem analysis
3.2 Technology landscape
3.3 Regulatory landscape
3.4 Industry impact forces
- 3.4.1 Growth drivers
  - 3.4.1.1 Upward trend in disease prevalence and demand for quick diagnostics
  - 3.4.1.2 Technological advancements in POCT devices
  - 3.4.1.3 Increasing R&D investment
- 3.4.2 Industry pitfalls and challenges
  - 3.4.2.1 Stringent regulatory framework
  - 3.4.2.2 High cost of product development
3.5 Growth potential analysis
- 3.5.1 By product
- 3.5.2 By end-use
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis, 2023
4.3 Competitive analysis of major market players, 2023
4.4 Competitive positioning matrix, 2023
4.5 Strategic outlook matrix, 2023

Chapter 5 Primary Care POC Diagnostics Market Size and Forecast, By Product, 2018-2032 (USD Million)

5.1 Key trends, by product
5.2 Glucose monitoring
5.3 Cardiometabolic testing products
- 5.3.1 Cardiac marker testing products
  - 5.3.1.1 hsTnl
  - 5.3.1.2 BNP
  - 5.3.1.3 D-dimer
  - 5.3.1.4 CK-MB
  - 5.3.1.5 Myoglobin
  - 5.3.1.6 Other cardiac market testing products
- 5.3.2 Blood gas/electrolytes testing products
- 5.3.3 HBA1C testing products
5.4 Infectious disease testing products
- 5.4.1 Influenza testing products
- 5.4.2 HIV testing products
- 5.4.3 Hepatitis C testing products
- 5.4.4 Sexually transmitted disease (STD) testing products
- 5.4.5 Healthcare-associated infection (HAI) testing products
- 5.4.6 Respiratory infection testing products
- 5.4.7 Tropical disease testing products
- 5.4.8 Other infectious disease testing products
5.5 Coagulation testing products
- 5.5.1 PT/INR testing products
- 5.5.2 Activated clotting time (ACT/APTT) testing products
5.6 Pregnancy and fertility testing products
- 5.6.1 Pregnancy testing products
- 5.6.2 Fertility testing products
5.7 Tumor/cancer marker testing products
5.8 Cholesterol testing products
5.9 Hematology testing products
5.10 Drug-of-abuse (DoA) testing products
5.11 Fecal occult testing products
5.12 Urinalysis testing products
5.13 Other products

Chapter 6 Primary Care POC Diagnostics Market Size and Forecast, By End-Use, 2018-2032 (USD Million)

6.1 Key trends, by end-use
6.2 Hospitals
6.3 Diagnostic centers
6.4 Research laboratories
6.5 Home-care settings
6.6 Other end-users

Chapter 7 Primary Care POC Diagnostics Market Size and Forecast, By Region, 2018-2032 (USD Million)

7.1 Key trends, by region
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Italy
- 7.3.5 Spain
- 7.3.6 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
- 7.4.6 Rest of Asia Pacific
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
- 7.5.4 Rest of Latin America
7.6 Middle East and Africa
- 7.6.1 Saudi Arabia
- 7.6.2 South Africa
- 7.6.3 UAE
- 7.6.4 Rest of Middle East and Africa